Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2676
Solid Power
SLDP
$463M
| $2.6M | ﹤0.01% |
1,003,000
+790,794
| +373% | +$2.44M |
2022 Q1
17 quarters
|
|
2677
CALL
QXO Inc
QXO
$12.1B
| $2.59M | ﹤0.01% |
+150,000
| New | +$2.79M |
2026 Q2
0 quarters
|
|
2678
Kiniksa Pharmaceuticals
KNSA
$7.33B
| $2.59M | ﹤0.01% |
40,513
+6,799
| +20% | +$353K |
2018 Q3
31 quarters
|
|
2679
PUT
Dollar General
DG
$28.8B
| $2.59M | ﹤0.01% |
22,500
-30,000
| -57% | -$3.41M |
2025 Q3
3 quarters
|
|
2680
Trustmark
TRMK
$2.6B
| $2.59M | ﹤0.01% |
56,285
+17,325
| +44% | +$772K |
2013 Q2
52 quarters
|
|
2681
Globus Medical
GMED
$10.7B
| $2.58M | ﹤0.01% |
32,700
+2,127
| +7% | +$181K |
2013 Q2
52 quarters
|
|
2682
10x Genomics
TXG
$8.51B
| $2.58M | ﹤0.01% |
67,385
+16,910
| +34% | +$443K |
2019 Q4
26 quarters
|
|
2683
Werner Enterprises
WERN
$1.72B
| $2.58M | ﹤0.01% |
59,233
+38,174
| +181% | +$1.44M |
2017 Q1
37 quarters
|
|
2684
Greif
GEF
$4.62B
| $2.58M | ﹤0.01% |
34,668
-24,473
| -41% | -$1.64M |
2013 Q2
52 quarters
|
|
2685
Viridian Therapeutics
VRDN
$2.85B
| $2.58M | ﹤0.01% |
140,415
+116,957
| +499% | +$1.88M |
2021 Q4
18 quarters
|
|
2686
Blue Bird Corp
BLBD
$1.97B
| $2.58M | ﹤0.01% |
32,665
-27,708
| -46% | -$1.88M |
2017 Q4
34 quarters
|
|
2687
Opendoor
OPEN
$1.69B
| $2.58M | ﹤0.01% |
557,793
+516,145
| +1,239% | +$2.47M |
2021 Q1
21 quarters
|
|
2688
United States Copper Index Fund
CPER
$720M
| $2.57M | ﹤0.01% |
+68,017
| New | +$2.56M |
2026 Q2
0 quarters
|
|
2689
CALL
Keel Infrastructure Corp
KEEL
$1.35B
| $2.55M | ﹤0.01% |
+445,000
| New | +$1.91M |
2026 Q2
0 quarters
|
|
2690
Protolabs
PRLB
$1.65B
| $2.55M | ﹤0.01% |
31,308
+16,100
| +106% | +$1.13M |
2013 Q2
52 quarters
|
|
2691
Harmony Biosciences
HRMY
$2.16B
| $2.55M | ﹤0.01% |
70,086
-29,576
| -30% | -$933K |
2020 Q4
22 quarters
|
|
2692
Levi Strauss
LEVI
$8.77B
| $2.55M | ﹤0.01% |
102,673
+27,282
| +36% | +$615K |
2019 Q1
29 quarters
|
|
2693
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
$12.9B
| $2.55M | ﹤0.01% |
61,078
-5,591
| -8% | -$223K |
2024 Q3
7 quarters
|
|
2694
iShares MSCI Chile ETF
ECH
$798M
| $2.55M | ﹤0.01% |
64,130
-4,167
| -6% | -$171K |
2025 Q4
2 quarters
|
|
2695
iShares Russell 2500 ETF
SMMD
$4.21B
| $2.55M | ﹤0.01% |
27,780
-3,276
| -11% | -$281K |
2023 Q2
12 quarters
|
|
2696
State Street SPDR S&P Semiconductor ETF
XSD
$2.45B
| $2.54M | ﹤0.01% |
4,080
-286
| -7% | -$150K |
2016 Q3
39 quarters
|
|
2697
iShares S&P Small-Cap 600 Growth ETF
IJT
$7.51B
| $2.54M | ﹤0.01% |
14,208
+28
| +0.2% | +$4.54K |
2013 Q2
52 quarters
|
|
2698
Photronics
PLAB
$1.65B
| $2.52M | ﹤0.01% |
77,537
-124,016
| -62% | -$5.25M |
2013 Q2
52 quarters
|
|
2699
Evolent Health
EVH
$486M
| $2.52M | ﹤0.01% |
465,146
-346,949
| -43% | -$1.33M |
2015 Q2
44 quarters
|
|
2700
Douglas Emmett
DEI
$1.65B
| $2.52M | ﹤0.01% |
213,558
+6,118
| +3% | +$68.8K |
2013 Q2
52 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.